StrideBio's Seed VC Round

StrideBio raised a round of funding on June 01, 2017. Investors include Hatteras Venture Partners.

StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. The company is building a proprietary therapeutic pipeline focused on rar…

Articles about StrideBio's Seed VC Round: